Chris A. Rallis - 20 Oct 2022 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Director
Signature
/s/ Chris A, Rallis
Issuer symbol
FENC
Transactions as of
20 Oct 2022
Net transactions value
-$12,082
Form type
4
Filing time
20 Oct 2022, 16:15:08 UTC
Previous filing
18 Jul 2022
Next filing
17 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common Shares Options Exercise $5,000 +4,762 +17% $1.05* 32,419 20 Oct 2022 Direct F1
transaction FENC Common Shares Tax liability $17,082 -2,068 -6.4% $8.26 30,351 20 Oct 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents options granted on November 11, 2012, with a $1.05 USD strike price and an expiration of November 11, 2022.
F2 Represents shares automatically sold pursuant to a 10b5-1 plan to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the exercise of 4,762 shares from an November 11, 2012 grant.